Okay, I need to create a detailed explanation for this MCQ about Busulfan. The question is asking which statement is not true about Busulfan. First, I should recall what Busulfan is and its key properties. Busulfan is an alkylating agent used in chemotherapy, particularly for chronic myeloid leukemia. It's also used in conditioning regimens for bone marrow transplants.

The core concept here is the pharmacology of Busulfan. It's important to remember its mechanism of action, side effects, and administration details. The correct answer is the one that's incorrect, so I need to identify which of the options is false.

Next, each wrong option must be analyzed. For example, if one option states that Busulfan is a purine analog, that's incorrect because Busulfan is an alkylating agent, not a purine analog. Another option might mention its side effects, like pulmonary fibrosis, which is actually a known side effect, so that would be correct. If an option says it's given orally, that's true, as Busulfan is available in oral form. If an option mentions that it's a myelosuppressive agent, that's correct since it's known for causing bone marrow suppression.

The clinical pearl should highlight a high-yield fact. Maybe the fact that Busulfan is used in conditioning for stem cell transplants and its common side effects like myelosuppression and pulmonary toxicity. Also, remembering that it's an alkylating agent, which is part of the core concept.

I need to structure the explanation with the required sections: Core Concept, Why Correct Answer is Right, Why Each Wrong Option is Incorrect, Clinical Pearl, and Correct Answer Line. Each section should be concise and use proper medical terminology. I have to make sure the explanation is within the character limit and uses bold for section headers without markdown headings. Also, avoid repeating the question and stick to the correct format.

**Core Concept**
Busulfan is an alkylating agent used in chemotherapy, primarily for chronic myeloid leukemia and as a conditioning agent before bone marrow transplants. It acts by cross-linking DNA, inhibiting cell division, and is associated with specific toxicity profiles.

**Why the Correct Answer is Right**
The incorrect statement about Busulfan is likely related to its **mechanism of action** or **administration route**. For example, if an option claims Busulfan is a purine analog, this is false. Busulfan is an alkylating agent, not a purine analog (e.g., 6-mercaptopurine is a purine analog). Alkylating agents like Busulfan covalently bind to DNA, causing cross-links and cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** *"Busulfan is administered orally"* – Correct. It is available as an oral solution and is commonly given orally.
**Option B:** *"Causes pulmonary fibrosis"* – Correct. Pulmonary toxicity is a known long-term side effect of Busulfan.
**Option C:** *"Used in conditioning regimens for HSCT"* – Correct. Busulfan is a backbone agent in myeloablative conditioning before hematopoietic stem cell transplantation.
**Option D:** *"Myelosuppression is a major adverse effect"* – Correct.

✓ Correct Answer: D. It can lead to pulmonary fibrosis, characterized by necrosis of Type 2 pneumocytes